Carbon Logic Biotech
License-out partnership of colorectal cancer molecular diagnostics
Carbon Logic Biotech develops molecular diagnostics, prognostic and predictive tests for colorectal cancer patients. Our molecular diagnostics address unmet medical needs of colorectal cancer patients. These tests are validated using our proprietary RNAseq datasets of formalin-fixed, paraffin-embedded (FFPE) samples. We seek a partner to license out our 3 molecular diagnostics products.
Medical Device:
Demand Type:
Looking for licensing partnership
Expiration:
December 30, 2024
Upcoming Conference
Nov. 12th, 2022
CABS Conference
The BioPacific Conference is the annual flagship event of the CABS. Our mission is to bring scientists, executives, and bio-pharmaceutical professionals from the Pacific Rim countries together to discuss the latest advances in the world of life sciences, the unprecedented challenges and promises facing the industry, and the breath-taking developments and opportunities in Asia/Pacific countries
Contact us
